3 Feb 2026
Benzimidazole-derived VEGFR-2 inhibitors: Docking, ADMET, anticancer evaluations, design and synthesisPublisher siteJournal of Molecular Structure, Angiogenesis and VEGF in Cancer
UniversitiesHelmy Sakr
Active, last published 2026
In synthesis and biological activity
Helmy
Sakr
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Al-Azhar University
Claim Your Profile22
H-index
1.6k
Citations
Helmy has not officially claimed their profile. If you are Helmy, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
elmy Sakr is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Helmy's work has been cited 1,588 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×24Synthesis and Biological Evaluation×12Cancer therapeutics and mechanisms×10Quinazolinone synthesis and applications×9Angiogenesis and VEGF in Cancer×6
04 · Where I am
Affiliations
Affiliation on published researchAl-Azhar UniversityDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Helmy?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you